Painreform Ltd Total Liabilities
Painreform Ltd total liabilities. Based on the latest financial reports, Painreform Ltd (PRFX) has total liabilities worth $2.72 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Painreform Ltd (PRFX) defensive interval to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Painreform Ltd (2017–2024)
Total liabilities of Painreform Ltd from 2017 to 2024. This chart illustrates how Painreform Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Painreform Ltd (PRFX) asset resilience to evaluate the company's liquid asset resilience ratio.
Painreform Ltd Competitors by Total Liabilities
The table below lists competitors of Painreform Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Im Cannabis Corp
NASDAQ:IMCC
|
USA | $35.35 Million |
|
Avinger Inc
NASDAQ:AVGR
|
USA | $9.73 Million |
|
BELGRAVIA HARTFORD CAP.
F:ECA
|
Germany | €2.63 Million |
|
Next Biometrics Group ASA
OL:NEXT
|
Norway | Nkr28.44 Million |
|
Montanaro UK Smaller Companies Investment Trust PLC
LSE:MTU
|
UK | GBX11.48 Million |
|
Savannah Resources Plc
LSE:SAV
|
UK | GBX6.06 Million |
|
BBS-Bioactive Bone Substitutes Oyj
HE:BONEH
|
Finland | €5.58 Million |
|
WILDCAT PRETR.LS -000028
F:8Y6
|
Germany | €54.00K |
Liability Composition Analysis (2017–2024)
This chart breaks down Painreform Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PRFX current and non-current assets.
Liquidity & Leverage Metrics
Painreform Ltd Total Liabilities Ratios Explained
Painreform Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Painreform Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Painreform Ltd (2017–2024)
The table below shows the annual total liabilities of Painreform Ltd from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $2.70 Million | +0.37% |
| 2023-12-31 | $2.69 Million | +105.89% |
| 2022-12-31 | $1.31 Million | +31.89% |
| 2021-12-31 | $991.00K | -16.09% |
| 2020-12-31 | $1.18 Million | -82.60% |
| 2019-12-31 | $6.79 Million | +49.54% |
| 2018-12-31 | $4.54 Million | +18.08% |
| 2017-12-31 | $3.84 Million | -- |
About Painreform Ltd
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinica… Read more